Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Wyles

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Clinics in Liver Disease|October 16, 2015
Regimens for Patients Coinfected with Human Immunodeficiency VirusDavid L Wyles
Infectious Disease Clinics of North America|October 23, 2012
Hepatitis C virus drug resistance: implications for clinical managementDavid L Wyles
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2008
Hepatitis virus coinfection in the Strategic Management of Antiretroviral Therapy (SMART) study: a marker for nonliver, non-opportunistic disease mortalityDavid L Wyles
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|November 26, 2010
Moving beyond interferon alfa: investigational drugs for hepatitis C virus infectionDavid L Wyles
Clinics in Liver Disease|July 4, 2019
Antiretroviral Effects on HBV/HIV Co-infection and the Natural History of Liver DiseaseDavid L Wyles
The Journal of Infectious Diseases|February 8, 2013
Antiviral resistance and the future landscape of hepatitis C virus infection therapyDavid L Wyles
Current HIV/AIDS Reports|November 9, 2017
Resistance to DAAs: When to Look and When It MattersDavid L Wyles
Topics in Antiviral Medicine|November 17, 2012
Beyond telaprevir and boceprevir: resistance and new agents for hepatitis C virus infectionDavid L Wyles
Hepatology (Baltimore, Md.)|September 17, 2016
Emerging complexities with hepatitis C virus direct-acting antiviral regimens: Less is still Way moreLucas A Hill, David L Wyles
Topics in Antiviral Medicine|August 9, 2021
CROI 2021: Viral Hepatitis and Other Forms of Liver Injury Impacting People with HIVAnne F Luetkemeyer, David L Wyles
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Clinics in Liver Disease|October 16, 2015
Regimens for Patients Coinfected with Human Immunodeficiency VirusDavid L Wyles
Infectious Disease Clinics of North America|October 23, 2012
Hepatitis C virus drug resistance: implications for clinical managementDavid L Wyles
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2008
Hepatitis virus coinfection in the Strategic Management of Antiretroviral Therapy (SMART) study: a marker for nonliver, non-opportunistic disease mortalityDavid L Wyles
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|November 26, 2010
Moving beyond interferon alfa: investigational drugs for hepatitis C virus infectionDavid L Wyles
Clinics in Liver Disease|July 4, 2019
Antiretroviral Effects on HBV/HIV Co-infection and the Natural History of Liver DiseaseDavid L Wyles
The Journal of Infectious Diseases|February 8, 2013
Antiviral resistance and the future landscape of hepatitis C virus infection therapyDavid L Wyles
Current HIV/AIDS Reports|November 9, 2017
Resistance to DAAs: When to Look and When It MattersDavid L Wyles
Topics in Antiviral Medicine|November 17, 2012
Beyond telaprevir and boceprevir: resistance and new agents for hepatitis C virus infectionDavid L Wyles
Hepatology (Baltimore, Md.)|September 17, 2016
Emerging complexities with hepatitis C virus direct-acting antiviral regimens: Less is still Way moreLucas A Hill, David L Wyles
Topics in Antiviral Medicine|August 9, 2021
CROI 2021: Viral Hepatitis and Other Forms of Liver Injury Impacting People with HIVAnne F Luetkemeyer, David L Wyles
Pageof 8